Pretransplant Hepatitis C Virus Treatment Decreases Access to High-quality Livers

BACKGROUND. Despite the revolutionary role of direct-acting antivirals for hepatitis C virus (HCV), the treatment timing for liver transplant candidates remains controversial. We hypothesize that deferring treatment until after liver transplantation improves access to a larger and higher-quality don...

Descripción completa

Detalles Bibliográficos
Autores principales: Strauss, Alexandra T., Ishaque, Tanveen, Weeks, Sharon, Hamilton, James P., Simsek, Cem, Durand, Christine M., Massie, Allan B., Segev, Dorry L., Gurakar, Ahmet, Garonzik-Wang, Jacqueline M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Liver Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440014/
https://www.ncbi.nlm.nih.gov/pubmed/34549082
http://dx.doi.org/10.1097/TXD.0000000000001127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440014/
https://www.ncbi.nlm.nih.gov/pubmed/34549082
http://dx.doi.org/10.1097/TXD.0000000000001127

Ejemplares similares